Search research articles
Contact Us
Filters
Showing results (61-70 of 234) with videos related to
Page
of 24
Sort By:
Blood Advances
|
November 10, 2020
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
Betül Oran, Marcos de Lima, Guillermo Garcia-Manero, et al.
Blood Advances
|
April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies
Supawee Saengboon, Stefan Ciurea, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
Ginna G Laport, Juan Wu, Brent Logan, et al.
The Journal of Antimicrobial Chemotherapy
|
April 11, 2013
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
Dimpy P Shah, Shashank S Ghantoji, Jharna N Shah, et al.
Blood
|
January 17, 2012
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
Roy F Chemaly, Santosh S Hanmod, Dhanesh B Rathod, et al.
Haematologica
|
March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphoma
Jeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
American Journal of Hematology
|
September 28, 2011
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation
Richard W Joseph, Amin Alousi, Bhavana Konda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
Maricer P Escalón, Richard E Champlin, Rima M Saliba, et al.
Blood
|
April 5, 2014
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
Dimpy P Shah, Shashank S Ghantoji, Ella J Ariza-Heredia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
Manuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Page
of 24
Search research articles
Search
Showing results (61-70 of 234) with videos related to
Sort By:
Page
of 24
Blood Advances
|
November 10, 2020
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
Betül Oran, Marcos de Lima, Guillermo Garcia-Manero, et al.
Blood Advances
|
April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies
Supawee Saengboon, Stefan Ciurea, Uday Popat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
Ginna G Laport, Juan Wu, Brent Logan, et al.
The Journal of Antimicrobial Chemotherapy
|
April 11, 2013
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
Dimpy P Shah, Shashank S Ghantoji, Jharna N Shah, et al.
Blood
|
January 17, 2012
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
Roy F Chemaly, Santosh S Hanmod, Dhanesh B Rathod, et al.
Haematologica
|
March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphoma
Jeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
American Journal of Hematology
|
September 28, 2011
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation
Richard W Joseph, Amin Alousi, Bhavana Konda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
Maricer P Escalón, Richard E Champlin, Rima M Saliba, et al.
Blood
|
April 5, 2014
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
Dimpy P Shah, Shashank S Ghantoji, Ella J Ariza-Heredia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
Manuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Page
of 24